Plasma osteopontin concentrations in patients with cutaneous melanoma

An effective circulating tumour marker is needed for melanoma especially with the advent of targeted therapies. Gene expression studies examining primary melanomas have shown that increased expression of osteopontin (SPP1) is associated with poor prognosis. Studies subsequently reported higher blood...

Full description

Saved in:

Bibliographic Details
Main Authors:	FILIA, A., ELLIOTT, F., WIND, T., FIELD, S., DAVIES, J., KUKALIZCH, K., RANDERSON-MOOR, J., HARLAND, M., BISHOP, D.T., BANKS, R.E., NEWTON-BISHOP, J.A.
Format:	Artigo
Language:	Inglês
Published:	D.A. Spandidos 2013
Subjects:	Articles
Online Access:	https://ncbi.nlm.nih.gov/pmc/articles/PMC3810214/ https://ncbi.nlm.nih.gov/pubmed/23934016 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/or.2013.2666
Tags:	Add Tag No Tags, Be the first to tag this record!

Plasma osteopontin concentrations in patients with cutaneous melanoma

Similar Items